DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 137 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,023,726 | -10.1% | 2,935,919 | -12.5% | 0.00% | 0.0% |
| Q2 2023 | $40,050,652 | +32.7% | 3,354,326 | +48.6% | 0.00% | 0.0% |
| Q1 2023 | $30,173,296 | -71.5% | 2,256,791 | -54.1% | 0.00% | -33.3% |
| Q4 2022 | $105,729,266 | +158.5% | 4,913,070 | +140.6% | 0.00% | 0.0% |
| Q3 2022 | $40,896,000 | +536.8% | 2,041,738 | +469.1% | 0.00% | – |
| Q2 2022 | $6,422,000 | +199.4% | 358,783 | +65.9% | 0.00% | – |
| Q1 2022 | $2,145,000 | -32.8% | 216,216 | +14.1% | 0.00% | – |
| Q4 2021 | $3,193,000 | +8.5% | 189,491 | +52.8% | 0.00% | – |
| Q3 2021 | $2,943,000 | – | 124,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |